← Browse by Condition
Medical Condition

univentricular heart

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for univentricular heart sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — univentricular heart Clinical Trials

How many clinical trials are currently recruiting for univentricular heart?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for univentricular heart, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for univentricular heart?
univentricular heart research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a univentricular heart clinical trial?
Eligibility criteria for univentricular heart trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
HeartWorks, Inc. 1 trial
Sisca Natalia Siagian 1 trial
Berlin Heart GmbH 1 trial

Recruiting Clinical Trials

NCT05647213 Phase 1
Recruiting
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
Enrollment
50 pts
Location
United States
Sponsor
HeartWorks, Inc.
View Trial →
NCT07535203
Recruiting
Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD
Enrollment
52 pts
Location
Indonesia
Sponsor
Sisca Natalia Siagian
View Trial →
NCT04782232
Recruiting
Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/Absence of the Right Heart
Enrollment
20 pts
Location
Germany
Sponsor
Berlin Heart GmbH
View Trial →

Related Conditions

congenital heart disease (1) heart failure nyha class iii (1) heart failure nyha class iv (1) congenital heart disease chd (1) heart failure (1) ventricular dysfunction (1) heart diseases (1) cardiovascular diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology